Levels of estrogen and progesterone shift unevenly and unpredictably through perimenopause, causing hormonal symptoms, which include: Irregular periods and reduced fertility Hot flashes Insomnia Night sweats Changes in mood: depression, mood swings, and irritability Changes in sexual function: vaginal dryness and atrophy, painful intercourse, low libido, reduced sexual arousal, difficulty achieving orgasm Weight gain Breast tenderness Brain fog, forgetfulness, and difficulty concentrating (7, 30) Reductions in estrogen levels are also associated with increased risk for vaginal and urinary tract infections, osteopenia, osteoporosis, dyslipidemia, and heart disease (39)
By pairing evidence-based medicine with a deeply human approach, Ro strives to help patients feel seen, supported, and empowered to take control of their weight in a way theyve never been able to before. On Ro, you can get access to some of the most effective GLP-1 medications approved by the US Food and Drug Administration (FDA) alongside structured, ongoing care from a licensed provider
Semaglutide also slows down the rate at which food leaves your stomach
P = .01) compared with other GLP-1 agents
This dose selection was informed by the Phase 2 observation that the 36 mg and 45 mg doses showed only modestly different efficacy but the 45 mg dose carried higher rates of gastrointestinal adverse events
Novo Nordisk had previously sent a cease and desist letter to Eli Lilly
